European regulators say they have positively confirmed that the recently recalled MS drug Zinbryta had health risks that outweighed any potential benefits, indicating that causes of severe brain inflammation were…
Tag Archives: Meningoencephalitis
A new study indicates that Zinbryta side effects were so severe it could have never become a major drug product, raising questions as to why it was approved when there…
The FDA says it will help multiple sclerosis patients transition to other drugs following a Zinbryta recall, and will let it stay on the market until the end of April.
A Zinbryta recall has been announced following 12 cases of brain inflammation, including three deaths, linked to use of the multiple sclerosis drug.
Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths
A Zinbryta recall and ban has been recommended in the EU following a dozen reports of serious brain inflammation linked to at least three patient deaths.
More Top Stories
Reader testimonials highlight the severe tooth damage suffered by many Suboxone users as lawyers pursue product liability lawsuits against the manufacturers.
A Bard PowerPort lawsuit accuses the manufacturers of concealing known defects and complications from patients and the medical community.
Three plaintiffs have been awarded a combined total of more than $1.5 billion after filing Roundup lawsuits over their non-Hodgkin's lymphoma diagnoses.